Clinical Trial Update: Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years [Phase 1]

View source ↗

Summary

A Phase 1 safety and pharmacokinetic assessment of Sancuso (granisetron) and IV granisetron in children aged 2 to 5 years for chemotherapy-induced nausea and vo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Granisetron (granisetron)
• SANCUSO (GRANISETRON)

Snippet

Sponsor: Kyowa Kirin Pharmaceutical Development Ltd | Conditions: Chemotherapy Induced Nausea and Vomiting | Phase 1 | Status: WITHDRAWN